🇺🇸 FDA

Company profile · Sponsor

Moleculin

Moleculin Biotech

MBRX · NYSE biotech HOUSTON, TX, USA
Pipeline
9
Drugs
0
Patents
1

Quick answer

Moleculin (MBRX) is a biotech company. headquartered in HOUSTON, TX, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker MBRX
Exchange NYSE
Company type biotech
Headquarters HOUSTON, TX, USA
SEC CIK 0001659617

Pipeline (9)

Search pipeline →

  1. CYTARABINE, CYTARABINE, Liposomal Annamycin, 0.9% Sodium Chloride Injection, USP/Ph. Eur./BP/JP

    Moleculin

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  2. Placebo in combination with Cytarabine Injection

    Moleculin

    Acute Myeloid Leukaemia (AML)

    phase 3 small molecule active

    1 trial

  3. ALEXAN, 50 MG/ML, ROZTWÓR DO INFUZJI, Liposomal Annamycin

    Moleculin

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  4. Liposomal Annamycin

    Moleculin

    Leukemia, Myeloid, Acute

    phase 2 small molecule completed

    3 trials

  5. Liposomal Annamycin (L-Annamycin)

    Moleculin

    Sarcoma,Soft Tissue

    phase 2 small molecule completed

    1 trial

  6. MOL4239

    Moleculin

    Psoriasis

    phase 2 small molecule completed

    1 trial

  7. STAT3 Inhibitor WP1066

    Moleculin

    Glioblastoma, IDH-Wildtype

    phase 2 small molecule active

    1 trial

  8. WP1122

    Moleculin

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  9. WP1220

    Moleculin

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 8450337

    Methods of treating skin disorders with caffeic acid analogs

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Moleculin?

Moleculin (MBRX) is a biotech company. headquartered in HOUSTON, TX, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Moleculin sponsor?

We track 9 ClinicalTrials.gov-linked programs for Moleculin, including CYTARABINE, CYTARABINE, Liposomal Annamycin, 0.9% Sodium Chloride Injection, USP/Ph. Eur./BP/JP and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Moleculin company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.